Latest Diabetes: Type II news

ADA: Combo Injectable Controls Blood Glucose Longer in T2DM

Compared with insulin glargine, initial injectable therapy with a combination of insulin degludec and liraglutide aids achievement of blood glucose goals for a longer period of time in patients with uncontrolled type 2 diabetes on oral antidiabetic drugs, according to a study published online June 9 in The Lancet Diabetes & Endocrinology to coincide with the annual meeting of the American Diabetes Association, held from June 7 to 11 in San Francisco.

Behavioral Intervention Ups Physical Activity in T2DM

A behavioral intervention results in a sustained increase in physical activity and decrease in sedentary time among patients with type 2 diabetes, according to a study published in the March 5 issue of the Journal of the American Medical Association.

Automated Insulin System Improves Glycemic Control

The combination of an automated guidance system for insulin titration and support from health care professionals is safe and is associated with significant improvements in glycemic control among patients with type 2 diabetes, according to a study published online Feb. 23 in The Lancet.

Kidney Disease Affects Revascularization Outcomes

The presence of comorbid chronic kidney disease negatively impacts myocardial revascularization outcomes in patients with type 2 diabetes mellitus, according to a study published in the Feb. 5 issue of the Journal of the American College of Cardiology.